Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	1 Months Ended	2 Months Ended	3 Months Ended
	Jan. 26, 2022	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities:
Net (loss) income	$ (40,460)	$ (38,059)	$ 6,743
Adjustments to reconcile net (loss) income to net cash (used for) provided by operating activities:
Depreciation and amortization	1,000	23,311	3,689
Share-based compensation	27,698	27,167	146
Amortization of debt issuance costs	0	911	565
Amortization of right-of-use assets	115	283	0
Write-down of internal use software development costs	0	676	255
Write-down of contingent consideration liability	0	0	63
Change in fair value of contingent consideration and CEO equity profit interest	(9)	1	1,412
Change in fair value of warrants	0	13,761	0
Deferred tax expense (benefits)	(816)	(17,141)	(274)
Changes in operating assets and liabilities—net of effect of acquisitions:
Accounts receivable, net of allowance for doubtful accounts	11,118	(14,522)	(4,471)
Due from related party	0	0	(252)
Prepaids and other assets	905	(9,920)	(1,029)
Accounts payable	(67,600)	66,170	5,306
Accrued expenses and other current liabilities	57,170	(171,340)	(958)
Deferred revenue	311	3,654	164
Long term earn-out liabilities	0	0	(27)
Other long-term liabilities	78	88,832	(1,204)
Net cash provided by (used for) operating activities	(10,490)	(26,216)	10,128
Cash flows from Investing Activities:
Purchases of property and equipment	0	(1,373)	0
Expenditures for internal-use software development costs	(441)	(922)	(1,440)
Purchase of businesses—net of cash acquired	0	(426,555)	0
Net cash (used for) investing activities	(441)	(428,850)	(1,440)
Cash flows from Financing Activities:
Proceeds from term loan and line of credit	0	449,000	0
Repayment of loan	0	(172,488)	0
Repayment of promissory note	0	0	(1,750)
Member capital contributions	0	0	147
Payments for financing costs	0	(24,423)	0
Redemptions of class A common stock	0	(510,469)	0
Cash received from backstop	0	246,484	0
Payments on contingent consideration from purchase of companies	0	0	(5,000)
Distributions to members	0	(247)	0
Net cash (used for) provided by financing activities	0	(12,143)	(6,603)
Effect of exchange rate changes in cash, cash equivalent and restricted cash	(132)	(237)	(245)
Net Increase (decrease) in cash	(11,063)	(467,446)	1,840
Cash and cash equivalents and restricted cash, beginning of the period	48,639	37,576	29,013
Cash and cash equivalents and restricted cash, end of the period	37,576	50,107	30,853
Reconciliation of cash, cash equivalents and restricted cash to the Consolidated Balance Sheets:
Cash and cash equivalents	36,833	42,178	30,853
Restricted cash	743	7,929	0
Total cash, cash equivalents and restricted cash	37,576	50,107	30,853
Supplemental cash flow information:
Cash paid for interest	0	932	3,762
Cash paid for taxes	241	261	518
Supplemental schedule of non-cash operating activities
ROU assets obtained in exchange for operating lease liabilities	$ 7,987	$ 0	$ 0